<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03227783</url>
  </required_header>
  <id_info>
    <org_study_id>17-0051</org_study_id>
    <nct_id>NCT03227783</nct_id>
  </id_info>
  <brief_title>The Effect of Transcranial Direct Current Stimulation (tDCS) on Depression in PD</brief_title>
  <official_title>The Effect of Transcranial Direct Current Stimulation (tDCS) on Depression in Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inje University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inje University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Depression is common in Parkinson's disease (PD), but the effective treatment is not
      established yet. tDCS is a non-invasive brain stimulation to modulate brain function. The
      tDCS on the depression in general population were already conducted, but not in PD. This
      study is to know whether transcranial direct current stimulation (tDCS) is effective for the
      treatment of depression in PD. Participant will be asked to visit three consecutive days for
      the non-invasive stimulation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">August 2017</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized, Parallel, Sham-controlled, single-blinded study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>BDI score</measure>
    <time_frame>(1) before the1st visit (within one month) (2) right after the 3rd tDCS (3) within one months after the 3rd tDCS</time_frame>
    <description>The changes of Beck depression inventory after tDCS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>HDRS score</measure>
    <time_frame>(1) before the 1st visit (within one month) (2) right after 3rd tDCS, within 24 hours (3) within one months after the 3rd tDCS</time_frame>
    <description>The changes of Hamilton Depression Rating Scale after tDCS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MADRS score</measure>
    <time_frame>(1) before the 1st visit (within one month) (2) right after the 3rd tDCS, within 24 hours (3) within one months after 3rd tDCS</time_frame>
    <description>The changes of Mongomery-Asberg Depression Rating Scale after tDCS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>resting state functional MRI</measure>
    <time_frame>(1) before the 1st visit (within one month) (2) after the 3rd tDCS, within 24 hours (on the same day as the 3rd tDCS)</time_frame>
    <description>The changes of resting state functional MRI after tDCS</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">26</enrollment>
  <condition>Parkinson's Disease</condition>
  <arm_group>
    <arm_group_label>Real tDCS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Constant weak electric currents through scalp via two electrodes will be delivered.
Current intensity: 2mA, 20min/day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>a 1 mA current, for 30 s giving an initial sensation of tDCS while minimizing stimulatory effects
Ramp up and ramp down was over 10 s. (Ref. Loo CK et al., Br J Psychiatry 2012;200:52-9)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcranial direct current stimulation (tDCS)</intervention_name>
    <description>tDCS is one of non-invasive brain stimulation. Constant, low current is delivered to the specific brain areas to change brain plasticity.</description>
    <arm_group_label>Real tDCS</arm_group_label>
    <arm_group_label>Sham tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  UK Parkinson's disease brain bank criteria

          -  more than 19 years old

          -  Able to provide consent for the protocol

          -  Depression (based on DSM-IV criteria)

        Exclusion Criteria:

          -  Dementia

          -  Unpredictable symptom fluctuations

          -  Contraindication to tDCS (i) irritations, cuts, lesions in the brain (ii) any
             preexisting unstable medical conditions, or conditions that may increase the risk of
             stimulation such as uncontrolled epilepsy (iii) history of severe cranial trauma with
             alteration of the cranial anatomy or metallic intracranial implants (iv) history of
             seizure

          -  Subjects without the capacity to give informed consent

          -  If participation in the study would, in the opinion of the investigators, cause undue
             risk or stress for reasons such as excessive fatigue, general frailty, or excessive
             apprehension
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sang Jin Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inje University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sang Jin Kim, MD, PhD</last_name>
    <phone>82-51-890-8954</phone>
    <email>jsk120@hanmail.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Inje university, Busan Paik Hospital</name>
      <address>
        <city>Busan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sang-jin Kim, professor</last_name>
      <phone>82-10-9525-6207</phone>
      <email>jsk120@hanmail.net</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 17, 2017</study_first_submitted>
  <study_first_submitted_qc>July 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 24, 2017</study_first_posted>
  <last_update_submitted>July 19, 2017</last_update_submitted>
  <last_update_submitted_qc>July 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inje University</investigator_affiliation>
    <investigator_full_name>Sangjin Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

